Contact us on email@example.com to request access to our secure data room.
The company is currently developing a zero carbon energy solution for the maritime transport industry in conjunction with scientists at the US National Laboratory Idaho (www.inl.gov). The technology employs Thorium, a common element without the risks association with uranium enrichment. Thorium Technology was at the heart of US energy planning until federal funding was cut in 1983 at the height of the arms race when uranium was deemed more viable given the need for weapons grade plutonium. Thorium research is now being re-launched with a significant federally funded grant, and our Singapore company has signed an irrevocable, perpetual license to the technology for the maritime transport industry. The company is currently raising convertible loan with 5% interest per annum for 3 years for a conversion price of USD 7/share at a pre-cash value of USD 2 million.Full Details
The company is reinventing RFID and NFC for the mass market at a fraction of the current cost that caters to everyday objects. Their current products are being adopted by global companies across diverse markets including food & beverage, appliance and consumables, pharmaceuticals and security solutions. Shareholders include Cambridge Innovation Capital, Arm Holdings (Softbank), and Avery Denison, the world’s largest label company. The current fund raised is fully subscribed at a value of GBP 63.5 millionFull Details
Indonesia’s largest online marketplace that allows individuals and small & midsize business owners to open and maintain their own online store easily and free, while providing better and safer online shopping experience to their customers. As transactions value and online shopping frequency are still low, the company could trade at a significantly higher valuation upon increase of transaction value and online shopping frequency. Alibaba (BABA) owns 26.4% of Tokopedia since Aug 2017 as Tokopedia has overtaken Lazada to become the most popular online store in Indonesia.Full Details
Prisma is a specialist in interactive information technologies with a core focus on Visual Recognition (VR), Augmented Reality (AR), Gesture based solution, Healthcare Technologies and other solutions such as software development and security and business intelligence. Originally formed as a spinoff from IBM, it has individuals with decades of prior experience in top tech MNCs such as IBM, Motorola, Oracle and a world class customer base including Changi Airport, IKEA, Autostrada and Interpol.Full Details
A diagnostic company in Milltrust’ British Innovation Fund. It is launching a new, simple to use, point-of-care blood testing device that can perform up to eight simultaneous tests to your GP would request from a single pin-prick of blood in less than 5 minutes. The patented Attomarker technology uses disposable credit-card sized chip that slots into a handheld device docked to iPhone that provides rapid testing for the healthcare professional and the consumer markets. The company is currently valued at GBP 60 million pre-cash following agreements with NHS and Lloyd the Chemist.Full Details
MyRepublic is largely the Broadband equivalent of an MVNO (mobile virtual network operator) in the mobile space. The MVNO model is well established, and there are many successful companies that employ its strategy of leasing capacity and overlaying modern cloud-based and service-oriented strategies to turn a profit. MyRepublic currently generates USD 200 million revenue and trading at USD 600 million valuation. MyRepublic should hit $600m in revenues by 2021, implying a $1.8bn valuation using the same multiple (By comparison the entry valuation would be roughly $500m).Full Details
A segregated investment portfolio centred around creating globally competitive companies by leveraging the strengths and attributes of different geographical areas of the world to accelerate the benefit new discoveries to mankind and the cost of better proven healthcare. Future Health will invest in Healthcare, Medical Technology and Life Sciences companies, with a particular focus on ageing and related illness including brain health, general wellness, oncology and immunotherapy, cardio- vascular disease, and immunology and infectious disease.Full Details